Author: alcyon

annonce kol event

LIVE Q&A KOL EVENTTG4050: Individualized cancer Vaccinein HPV-Negative Head & Neck Cancers April 19, 2023 | 12:00 PM ET CLICK TO REGISTER & ATTEND

John C. Bell, PhD

Scientific advisor   John C. Bell, PhD, is an internationally renowned expert in using oncolytic viruses (OVs) to treat cancer. He formed, and continues to lead, the Canadian Oncolytic Virus Consortium, a trans-Canadian, multidisciplinary group developing virus-based cancer therapeutics. He is the Scientific Director of BioCanRx, a Network of Centers of Excellence developing and clinically… Continue reading John C. Bell, PhD

Pedro Romero, MD

Scientific advisor    Pedro Romero, MD, is Professor at the Faculty of Biology and Medicine, University of Lausanne, where he has worked since 2003, focusing on tumor immunology and cancer immunotherapy, particularly on the biology and dynamics of cytolytic CD8 T lymphocyte (CTL) responses. He is also Editor-in-Chief of the Journal for ImmunoTherapy of Cancer. Previously,… Continue reading Pedro Romero, MD

produits : TG6050 – en

TG6050 TG6050, an innovative oncolytic virus from the Invir.IO® platform, armed oncolytic virus given by intravenous administration. TG6050 has been engineered to express human IL-12, a cytokine that triggers a powerful antitumor immune response, and a full length anti-CTLA4 antibody.    Discover how TG6050 works A novel immunotherapy TG6050 is based on a patented viral… Continue reading produits : TG6050 – en